ArticleTransplantation and cellular therapy2025

Two Nonmyeloablative HLA-Matched Related Donor Allogeneic Hematopoietic Cell Transplantation Regimens in Patients with Severe Sickle Cell Disease.

Zaina Inam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.